Eric Quéméneur
Chief Tech/Sci/R&D Officer presso TRANSGENE
Posizioni attive di Eric Quéméneur
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TRANSGENE | Chief Tech/Sci/R&D Officer | 01/09/2014 | - |
| ELSALYS BIOTECH | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
Storia della carriera di Eric Quéméneur
Precedenti posizioni note di Eric Quéméneur
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Comité de l’énergie Atomique | Corporate Officer/Principal | 01/09/2010 | 01/09/2014 |
Formazione di Eric Quéméneur
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| Institut National des Sciences Appliquées de Lyon | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Francia | 6 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Government | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Aziende private | 2 |
|---|---|
| Comité de l’énergie Atomique | Government |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Borsa valori
- Insiders
- Eric Quéméneur
- Esperienza
